Published in Ann Intern Med on November 01, 1986
Physical diagnosis versus modern technology. A review. West J Med (1990) 1.49
Limitations of transoesophageal echocardiography in patients with focal cerebral ischaemic events. Br Heart J (1992) 1.01
Transcranial Doppler ultrasonography in the detection of venous to arterial shunting in acute stroke and transient ischaemic attacks. J Neurol Neurosurg Psychiatry (1996) 0.86
Prognosis of retinal infarction. BMJ (1991) 0.75
Idiopathic ischemic infarction of the brain stem in children. Childs Nerv Syst (1991) 0.75
Stroke in young people--the heart of the matter. West J Med (1987) 0.75
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clin Pharmacol Ther (2011) 4.42
Clinical use of the total artificial heart. N Engl J Med (1984) 2.94
A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction. N Engl J Med (1983) 2.85
ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol (1996) 2.81
The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport. N Engl J Med (1984) 2.71
An emergency department-based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense: results of a randomized study (ROMIO). J Am Coll Cardiol (1996) 2.46
Restricted transport in small pores. A model for steric exclusion and hindered particle motion. Biophys J (1974) 2.42
The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis (1988) 2.42
Comparison of adrenergic beta-receptor antagonists in angina pectoris. Br Med J (1973) 2.31
Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet (1968) 2.29
Comparison of antihypertensive activity of beta-blocking drugs during chronic treatment. Br Med J (1976) 2.23
Aortic valve incompetence and replacement in rheumatoid arthritis. Ann Rheum Dis (1975) 2.23
HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Validation study and meta-analysis of published HLA association studies. Circulation (1991) 2.22
Integration of genetic, clinical, and INR data to refine warfarin dosing. Clin Pharmacol Ther (2010) 2.21
Time delays in the diagnosis and treatment of acute myocardial infarction: a tale of eight cities. Report from the Pre-hospital Study Group and the Cincinnati Heart Project. Am Heart J (1990) 2.14
Mechanism of osmotic flow in porous membranes. Biophys J (1974) 2.07
Oral flecainide acetate for the treatment of ventricular arrhythmias. N Engl J Med (1981) 1.99
Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation (2000) 1.92
Standardized full-field electroretinography. Normal values and their variation with age. Arch Ophthalmol (1992) 1.92
Coronary spasm producing coronary thrombosis and myocardial infarction. N Engl J Med (1983) 1.91
Idiopathic cardiomyopathy, age, and suppressor-cell dysfunction as risk determinants of lymphoma after cardiac transplantation. Lancet (1978) 1.87
Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation (1998) 1.86
Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy. Ophthalmology (1999) 1.80
Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study. Circulation (2000) 1.74
Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation (1995) 1.73
Implementation of a computerized cardiovascular information system in a private hospital setting. Am Heart J (1998) 1.68
S-cone function in patients with retinitis pigmentosa. Invest Ophthalmol Vis Sci (1993) 1.65
Patient information recall in a rheumatology clinic. Rheumatol Rehabil (1979) 1.62
Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation (2001) 1.61
Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group. Circulation (1991) 1.59
HLA haplotypes in a family with multiple cases of rheumatoid arthritis. J Rheumatol (1982) 1.59
The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum (1994) 1.57
Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol (1996) 1.55
Determination of aortic valve area by two-dimensional and Doppler echocardiography in patients with normal and stenotic bioprosthetic valves. J Am Coll Cardiol (1990) 1.48
Partitioning and diffusion of proteins and linear polymers in polyacrylamide gels. Biophys J (1996) 1.46
Changes in spontaneous variability of ventricular ectopic activity as a function of time in patients with chronic arrhythmias. Circulation (1988) 1.45
Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris. N Engl J Med (1979) 1.44
Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST) Circulation (1994) 1.43
Patient preferences and the bedside manner. Med Educ (1982) 1.41
Pericarditis after acute myocardial infarction. Br Med J (1971) 1.39
Genetics informatics trial (GIFT) of warfarin to prevent deep vein thrombosis (DVT): rationale and study design. Pharmacogenomics J (2011) 1.38
Pulmonary veno-occlusive disease. Q J Med (1975) 1.37
Nuclear preparations of SV40-transformed cells contain tumor-specific transplantation antigen activity. Virology (1977) 1.37
Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris. Am J Med (1980) 1.36
Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol (1990) 1.35
Cardiac tamponade, constrictive pericarditis and pericardial resection in rheumatoid arthritis. Medicine (Baltimore) (1975) 1.29
Thrombolysis and myocardial salvage. Results of clinical trials and the animal paradigm--paradoxic or predictable? Circulation (1993) 1.28
Reduction in QT interval dispersion by successful thrombolytic therapy in acute myocardial infarction. TEAM-2 Study Investigators. Circulation (1994) 1.26
Malignant neoplasms following cardiac transplantation. JAMA (1978) 1.24
Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality. Am J Cardiol (2001) 1.24
Risk factors for congenital hypothyroidism: an investigation of infant's birth weight, ethnicity, and gender in California, 1990-1998. Teratology (2000) 1.23
Treatment of breast cancer: doctor/patient communication and psychosocial implications. Proc R Soc Med (1975) 1.23
Model pores of molecular dimension. The preparation and characterization of track-etched membranes. Biophys J (1972) 1.21
Kinetics and yield of singlet oxygen photosensitized by hypericin in organic and biological media. Photochem Photobiol (1998) 1.21
Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease. J Am Coll Cardiol (2000) 1.20
A randomized trial of intravenous and intracoronary streptokinase in patients with acute myocardial infarction. Circulation (1984) 1.19
Coffee consumption and cause-specific mortality. Association with age at death and compression of mortality. J Clin Epidemiol (1992) 1.17
Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy. Am J Cardiol (1982) 1.16
Hemodynamics at rest and during supine and sitting bicycle exercise in normal subjects. Am J Cardiol (1978) 1.15
Expression and thermal stability of simian virus 40 tumor-specific transplantation antigen and tumor antigen in wild type- and tsA mutant-transformed cells. J Virol (1977) 1.15
Neutrophil dysfunction in diabetes mellitus. J Lab Clin Med (1975) 1.15
SV40 transformation of mouse brain cells: critical role of gene A in maintenance of the transformed phenotype. J Cell Physiol (1976) 1.14
Generating genetic risk scores from intermediate phenotypes for use in association studies of clinically significant endpoints. Ann Hum Genet (2005) 1.13
HLA A, B and DR typing in idiopathic dilated cardiomyopathy: a search for immune response factors. Am J Cardiol (1984) 1.13
The effect of carbidopa on the pharmacokinetics of intravenously administered levodopa: the mechanism of action in the treatment of parkinsonism. Ann Neurol (1985) 1.13
Vancomycin pharmacokinetics, renal handling, and nonrenal clearances in normal human subjects. Clin Pharmacol Ther (1988) 1.12
Novel cardiac troponin T mutation as a cause of familial dilated cardiomyopathy. Circulation (2001) 1.12
Clinical evaluation of a diameter sensing Doppler cardiac output meter. Crit Care Med (1990) 1.11
A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy. Am J Cardiol (1985) 1.08
Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo. Am J Med (1990) 1.08
Lignocaine therapy for ventricular ectopic activity after acute myocardial infarction: a double-blind trial. Br Med J (1971) 1.08
Hamstrings vs. patella tendon for anterior cruciate ligament reconstruction: a randomised controlled trial. Knee (2001) 1.08
Impact of field-transmitted electrocardiography on time to in-hospital thrombolytic therapy in acute myocardial infarction. Am J Cardiol (1990) 1.07
Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainide. J Am Coll Cardiol (1986) 1.07
Oral isosorbide dinitrate in the treatment of angina pectoris. Dose-response relationship and duration of action during acute therapy. Circulation (1980) 1.06
Treatment of ventricular arrhythmias by United States cardiologists: a survey before the Cardiac Arrhythmia Suppression Trial results were available. Am J Cardiol (1990) 1.06
Genetic mapping of a novel familial form of infantile hemangioma. Am J Med Genet (1999) 1.05
Successful surgical repair of a ruptured aneurysm of the sinus of Valsalva in early pregnancy. Ann Intern Med (1991) 1.04
Tolerance to the circulatory effects of oral isosorbide dinitrate. Rate of development and cross-tolerance to glyceryl trinitrate. Circulation (1980) 1.03
Lack of influence of pretreatment antistreptokinase antibody on efficacy in a multicenter patency comparison of intravenous streptokinase and anistreplase in acute myocardial infarction. Am Heart J (1992) 1.03
Modulatory effects of heparin and short-length oligosaccharides of heparin on the metastasis and growth of LMD MDA-MB 231 breast cancer cells in vivo. Br J Cancer (2007) 1.03
Safety and tolerability of long-term propafenone therapy for supraventricular tachyarrhythmias. The Propafenone Multicenter Study Group. Am J Cardiol (1996) 1.03
The effect of yogic breathing exercises on mood. J Am Soc Psychosom Dent Med (1983) 1.02
Development of an in vivo model of human multiple myeloma bone disease. Blood (1996) 1.00
Familial automaticity-conduction disorder with associated cardiomyopathy. West J Med (1986) 1.00
Quantification of aortic regurgitation utilizing continuous wave Doppler ultrasound. J Am Coll Cardiol (1986) 0.99
Deficient natural killer cell activity in patients with idiopathic dilated cardiomyopathy. Lancet (1982) 0.97
Nitric oxide and thiol reagent modulation of Ca2+-activated K+ (BKCa) channels in myocytes of the guinea-pig taenia caeci. J Physiol (2000) 0.97
Comparative effects of beta-adrenergic blocking drugs on experimental ventricular fibrillation threshold. Am J Cardiol (1983) 0.96
Ruminal and intestinal degradability of distillers grains plus solubles varies by source. J Dairy Sci (2007) 0.96
Cytomegalovirus induction of interleukin-6 in lung fibroblasts occurs independently of active infection and involves a G protein and the transcription factor, NF-kappaB. J Infect Dis (1999) 0.95